Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Alignment Healthcare, Inc. (NASDAQ: ALHC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a Medicare Advantage-focused health insurer. Alignment files annual and quarterly reports, along with current reports on Form 8-K, that describe its financial condition, operations and key developments in its Medicare Advantage business.
Recent Form 8-K filings show that Alignment uses these reports to announce quarterly financial results and share information discussed with investors and analysts. For example, the company has filed 8-Ks to furnish press releases on second and third quarter results and to outline discussions of strategy, market position and preliminary CMS Star Ratings. These filings often reference non-GAAP measures such as adjusted gross profit and adjusted EBITDA, which are defined and reconciled to the most comparable GAAP measures in accompanying tables.
Alignment’s SEC filings also provide detail on revenue sources and expenses. Condensed consolidated statements of operations list earned premiums and other revenue, along with medical expenses, selling, general and administrative expenses, and depreciation and amortization. Balance sheet information includes medical expenses payable, long-term debt and stockholders’ equity, giving investors a structured view of the company’s capital and obligations.
Through this page, users can track ongoing 8-K disclosures related to earnings releases, guidance updates, investor presentations and other material events. Filings may also reference CMS Star Ratings, membership expectations and risk factors summarized in the company’s Form 10-K and other periodic reports. Stock Titan enhances access to these documents with AI-powered tools that help explain terminology, highlight key sections and summarize lengthy filings, allowing investors to more quickly understand how ALHC reports its performance, membership trends and risk profile.
General Atlantic and affiliated funds report beneficial ownership of 24,287,227 shares of Alignment Healthcare Class A common stock, representing 12.3% of the outstanding shares. The filing states the percentage is calculated using 198,031,417 shares outstanding as reported by the company in its quarterly report filed July 30, 2025. The shares are held by General Atlantic (ALN HLTH), L.P. (GA ALN) and beneficial ownership is shared across multiple General Atlantic entities and funds, with shared voting and dispositive power reported for 24,287,227 shares and no sole voting or dispositive power reported. The filing explains the intercompany relationships (general partners and managing members) that give rise to shared control and notes Michael Gosk signed on behalf of the reporting persons on September 24, 2025.
General Atlantic (ALN HLTH), L.P. sold 6,246,096 shares of Alignment Healthcare, Inc. (ALHC) on 09/17/2025 at $16.01 per share in a private placement, reducing the reporting entity's direct holdings to 24,287,227 shares. After the transaction, GA ALN reports indirect additional holdings of 135,716 shares and 18,710 restricted stock units held for two individuals for the benefit of General Atlantic Service Company, L.P. The filing identifies GA ALN and several affiliated General Atlantic funds and entities that may constitute a group but disclaims ownership beyond direct holdings. The Form 4 is signed by Michael Gosk on 09/19/2025.
General Atlantic entities reported a private sale of Alignment Healthcare common stock. On 09/17/2025, General Atlantic (ALN HLTH), L.P. sold 6,246,096 shares of ALHC at $16.01 per share in a private placement to a third party.
After the transaction GA ALN held 24,287,227 shares directly and, including certain shares and restricted stock units held for the benefit of General Atlantic Service Company, L.P., the reporting group beneficially owned 24,596,079 shares indirectly. Multiple General Atlantic affiliated entities are listed as reporting persons and may be deemed members of a group; each disclaimers ownership beyond direct holdings.
Joseph S. Konowiecki, a director of Alignment Healthcare, Inc. (ALHC), reported a non-discretionary sale of 16,076 shares of common stock on 09/16/2025 at a price of $16.24 per share. The sale represents shares withheld to satisfy tax withholding obligations tied to the vesting of restricted stock units and is explicitly described as not a discretionary trade. After the transaction, the reporting person beneficially owned 1,110,973 shares, held directly. The filing discloses routine insider tax-related share withholding rather than an open-market decision to reduce ownership.
General Atlantic (ALN HLTH), L.P. reported an open-market sale of 13,460,000 shares of Alignment Healthcare, Inc. (ALHC) that settled on 09/12/2025 at a net price of $16.01 per share. Following the transaction, GA ALN directly held 30,533,323 shares. The filing reports 30,842,175 shares beneficially owned in total on an indirect basis, which reflects additional shares and restricted stock units held by two individuals for the benefit of General Atlantic Service Company, L.P. The reporting entity is listed as both a director and a 10% owner. The form is signed by Michael Gosk on 09/16/2025.
General Atlantic reported an open-market sale of 13,460,000 shares of Alignment Healthcare (ALHC) common stock settled on 09/12/2025 at a net price of $16.01 per share. After the transaction, General Atlantic (GA ALN) held 30,533,323 shares directly and, when combined with certain shares and restricted stock units held for the benefit of General Atlantic Service Company, L.P., the reporting group is shown as beneficially owning 30,842,175 shares in the filing. The Form 4 identifies multiple related General Atlantic entities and states they may be deemed a group while disclaiming broader beneficial ownership. The filing is signed by Michael Gosk on 09/16/2025 and lists the reporting persons as directors-by-deputization for Section 16 purposes.
Alignment Healthcare, Inc. (ALHC) filed a Form 144 notifying the proposed sale of 13,460,000 shares of common stock through Morgan Stanley & Co. LLC with an aggregate market value of $215,494,600.00. The filing lists the approximate sale date as 09/10/2025 and shows 198,031,417 shares outstanding, implying the proposed sale represents roughly 6.8% of outstanding shares. The securities were acquired on 09/16/2016 in a corporate reorganization involving Alignment Healthcare, Inc., and payment/consideration details reference remarks. No securities sales by the person in the past three months were reported.
Alignment Healthcare insider Christopher J. Joyce, the companys Chief Legal and Administrative Officer and a director, reported two non-discretionary sales of common stock on 09/10/2025 to satisfy tax withholding for vested restricted stock units. Mr. Joyce sold 22,128 shares at a weighted-average price of $16.2293 (per-share trades ranged $15.74$16.735) and 8,811 shares at a weighted-average price of $16.8555 (per-share trades ranged $16.74$17.24). After these transactions he beneficially owns 352,403 and 343,592 shares as reported on each line, respectively. The filer certified the sales were to cover tax withholding and not discretionary trades.
Robert L. Scavo, Chief Information Officer and director of Alignment Healthcare, Inc. (ALHC), sold shares on 09/10/2025 to satisfy tax withholding from RSU vesting. The filing reports two non-discretionary sales: 21,123 shares at a weighted-average price of $16.2293 (individual trade prices ranged $15.74 to $16.735) and 8,412 shares at a weighted-average price of $16.8555 (individual trade prices ranged $16.74 to $17.24). After these transactions he beneficially owned 580,967 shares following the first set and 572,555 shares following the second set, held directly. The sales were executed pursuant to tax-withholding obligations and were not discretionary trades.
Alignment Healthcare insider sale under 10b5-1 plan; sales were tax-withholding for vested RSUs. On 09/10/2025 Dawn C. Maroney reported three non-discretionary sales of Alignment Healthcare (ALHC) common stock. The reported transactions were: sale of 77,555 shares at a weighted-average price of $16.2293 (per-share sales ranged $15.74–$16.735), sale of 30,884 shares at a weighted-average price of $16.8555 (range $16.74–$17.24), and sales totaling 107,223 shares under a Rule 10b5-1 plan adopted 05/22/2025 at a weighted-average price of $16.4163 (range $16.03–$16.73). Following these transactions the reporting person beneficially owned 1,797,237 shares.
FAQ
What is the current stock price of Alignment Healthcare (ALHC)?
What is the market cap of Alignment Healthcare (ALHC)?
